Korean Market
OTHR
Kanaph Therapeutics
★

Grant of Stock Options to Employees... Exercise Price Above Market, Limited Dilution, Minimal Shareholder Impact

 
OWNR
Kanaph Therapeutics
★

Non-registered Officer Kim Nam-ju Acquires 4,500 Shares via Exercise of Stock Purchase Rights

 
OWNR
Kanaph Therapeutics
★

Non-Executive Director Kim Dong-geon Acquires 8,250 Additional Shares via Stock Purchase Rights (0.11% to 0.18%)

 
OWNR
Kanaph Therapeutics
★

Executive VP Jang Ji-hoon exercises stock purchase rights for 25,000 shares at 1,500 won (1.40% stake)

 
PERI
Kanaph Therapeutics
★★

Kanaph Therapeutics Q1 2026: Cash holdings of 48.9bn won, KOSDAQ listing and technology transfer expansion